About this trial
Obstructive sleep apnea (OSA) is part of the sleep-disordered breathing spectrum. Its prevalence in children is 1-5%, and it can have negative consequences at the cardiovascular, cognitive as well as behavioral levels. In children, the first-line treatment is adenotonsillectomy. However, residual obstructive events can persist as the success rate of surgery reaches only 49% in non-obese children. Residual OSA may be explained by multiple sites of obstruction, found in 20-85% children concerned by persistent OSA. Indeed, the tongue appears among one possible primary sites of obstruction. Given the tongue's crucial role in upper-airway patency during sleep, its assessment can inform us about the myofunctional deficits involved in sleep-disordered breathing.
The primary objective of the present study is to assess tongue motor functions in children with sleep-disordered breathing and to compare them to those of healthy children (data collected in a current study (TMAC) conducted at UCLouvain, Belgium; NCT06166680), in order to document possible myofunctional deficits in children with OSA. The hypothesis is that tongue motor functions will be lower in children with sleep-disordered breathing.
Eligibility criteria
Qualifiers
With suspected sleep-disordered breathing
Referred for polysomnography
Affiliated to a social security scheme
With informed consent from both legal representatives
Disqualifiers
Insufficient comprehension of French language
Neurological, cardiac, or unstable respiratory conditions other than sleep disorders and their repercussions
Any deficit possibly impacting measurements according to the investigator (e.g., psychiatric condition)
Malformation of the skull, the upper airway or the oral cavity
Trial design
Treatments tested in this trial
- Tongue Strength Assessment
- Polysomnography
- Subjective Assessment of Sleep-Disordered Breathing
- Subjective Assessment of Daytime Functioning
- Anthropometry
- Clinical Examination
- Orofacial Praxis Assessment